Effect of Baseline MTX Dose on Clinical Efficacy and Safety in Rheumatoid Arthritis Patients Treated with Filgotinib: Post-Hoc Analysis from a Phase 2B Study

被引：0
|
作者：
Westhovens, Rene [1 ]
van der Aa, Annegret [2 ]
Jamoul, Corinne [2 ]
Tasset, Chantal [2 ]
Harrison, Pille [2 ]
机构：
[1] Katholieke Univ Leuven, Dept Dev & Regenerat, Skeletal Biol & Engn Res Ctr, Leuven, Belgium
[2] Galapagos NV, Mechelen, Belgium
来源：
ARTHRITIS & RHEUMATOLOGY | 2017年 / 69卷
关键词：
GLPG0634/GS-6034; INHIBITOR;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
534
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Efficacy and Safety of Sarilumab Plus MTX in Subgroups of Patients with Rheumatoid Arthritis in a Phase 3 Study
    Kavanaugh, Arthur
    Kivitz, Alan J.
    Miranda, P.
    Fiore, Stefano
    Fay, Jonathan
    Fan, Chunpeng
    van Adelsberg, Janet
    Huizinga, T. W. J.
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [42] EFFICACY AND SAFETY OF SARILUMAB PLUS MTX IN SUBGROUPS OF PATIENTS WITH RHEUMATOID ARTHRITIS IN A PHASE 3 STUDY
    Kavanaugh, Arthur
    Kivitz, Alan J.
    Miranda, Pedro C.
    Fiore, Stefano
    Fay, Jonathan
    Fan, Chunpeng
    Van Adelsberg, Janet
    Huizinga, Tom W. J.
    INTERNAL MEDICINE JOURNAL, 2016, 46 : 42 - 42
  • [43] Correction to: Effect of Golimumab Dose Escalation in Japanese Patients With Rheumatoid Arthritis: Post-Hoc Analysis of Post-Marketing Surveillance Data
    Hirohito Shimizu
    Hisanori Kobayashi
    Masayoshi Kanbori
    Yutaka Ishii
    Rheumatology and Therapy, 2020, 7 : 1053 - 1053
  • [44] Selinexor Efficacy and Safety Are Independent of Renal Function in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL): A Post-Hoc Analysis from the Pivotal Phase 2b Sadal Study
    Schuster, Michael W.
    Canales, Miguel A.
    Westin, Jason
    Zijlstra, Josee M.
    Follows, George A.
    Karmali, Reem
    Kalakonda, Nagesh
    Goy, Andre H.
    Casasnovas, Rene-Olivier
    Vermaat, Joost
    Van den Neste, Eric
    Choquet, Sylvain
    Thieblemont, Catherine
    Cavallo, Federica
    De La Cruz, Maria de Fatima
    Hill, Brian T.
    Tilly, Herve
    Kassam, Shireen
    Bouabdallah, Reda
    Jaeger, Ulrich
    Gurion, Ronit
    Caimi, Paolo
    Martin, Peter
    Davies, Andrew
    Smith, Sonali M.
    Collins, Graham P.
    Offner, Fritz C.
    Salles, Gilles
    Ma, Xiwen
    Corona, Kelly
    Saint-Martin, Jean-Richard
    Joshi, Anita A.
    Chamoun, Kamal
    Wang, Hongwei
    Shah, Jatin J.
    Shacham, Sharon
    Kauffman, Michael G.
    Maerevoet, Marie
    BLOOD, 2020, 136
  • [45] A Phase 2b Study Evaluating the Efficacy and Safety of Subcutaneously Administered Tregalizumab in Subjects with Active Rheumatoid Arthritis (RA) Despite Treatment with Methotrexate (MTX)
    van Vollenhoven, Ronald F.
    Keystone, Edward C.
    Strand, Vibeke
    Pacheco-Tena, Cesar
    Vencovsky, Jiri
    Behrens, Frank
    Zipp, Daniela
    Rharbaoui, Faiza
    Wolter, Ralf
    Tiemann, Rolf-Dietrich
    Knierim, Luise
    Schmeidl, Rainer
    Zhou, Xuefei
    Aigner, Silke
    Daelken, Benjamin
    Wartenberg-Demand, Andrea
    ARTHRITIS & RHEUMATOLOGY, 2015, 67
  • [46] Post-Hoc Analysis Showing Better Clinical Response With The Loading Dose Of Certolizumab Pegol In Japanese Patients With Active Rheumatoid Arthritis
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Tanaka, Yoshiya
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Kobayashi, Mariko
    Shoji, Toshiharu
    Miyasaka, Nobuyuki
    Koike, Takao
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S989 - S989
  • [47] Post-hoc analysis showing better clinical response with the loading dose of certolizumab pegol in Japanese patients with active rheumatoid arthritis
    Takeuchi, Tsutomu
    Yamamoto, Kazuhiko
    Yamanaka, Hisashi
    Ishiguro, Naoki
    Tanaka, Yoshiya
    Eguchi, Katsumi
    Watanabe, Akira
    Origasa, Hideki
    Kobayashi, Mariko
    Shoji, Toshiharu
    Togo, Osamu
    Miyasaka, Nobuyuki
    Koike, Takao
    MODERN RHEUMATOLOGY, 2016, 26 (04) : 473 - 480
  • [48] Dapirolizumab Pegol Efficacy by Subgroups in Patients with SLE: A Post Hoc Analysis of Phase 2b Clinical Trial Data
    Askanase, Anca
    Stach, Christian
    Brittain, Claire
    Stojan, George
    Furie, Richard
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 4622 - 4624
  • [49] HEPATIC SAFETY IN PATIENTS WITH RHEUMATOID ARTHRITIS WHO RECEIVED ISONIAZID FOR LATENT TUBERCULOSIS: POST-HOC ANALYSIS FROM PHASE 3 BARICITINIB STUDIES
    Hsieh, T-Y
    Huang, W. -N.
    Tony, H. -P.
    Balsa, A.
    Winthrop, K.
    Harigai, M.
    Dickson, C.
    Wu, W. -S.
    de la Torre, I.
    Liao, R.
    Chen, L.
    Kumar, S.
    Combe, B.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 593 - 593
  • [50] Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study
    Bernard G. Combe
    Yoshiya Tanaka
    Maya H. Buch
    Peter Nash
    Gerd R. Burmester
    Alan J. Kivitz
    Beatrix Bartok
    Alena Pechonkina
    Katrina Xia
    Kahaku Emoto
    Shungo Kano
    Thijs K. Hendrikx
    Robert B. M. Landewé
    Daniel Aletaha
    Rheumatology and Therapy, 2023, 10 : 53 - 70
12345